FDA Investigator Lisa Hornback
Lisa Hornback has conducted inspections on 40 sites in 4 countries as of 10 Apr 2002. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
40
Last Inspection Date:
10 Apr 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Italy,
Japan
FDA Investigators that have inspected at least one site in common with Lisa Hornback:
Alan M Barker,
Alicia M Mozzachio,
Allison A Aldridge, PhD,
Amanda Dinaro,
Amanda S Zorn,
Ana L Kewes,
Andrew J Barrowcliff,
Anna Flynn,
Benjamin J Dastoli,
Bradley J Maunder,
Brentley S Collins,
Brian D Nicholson,
Bruce H Mccullough,
Carrie Ann Plucinski,
Chad E Schmear,
Chad W Rice,
Chase S Baldwin,
Chiang Syin, PhD,
Christina A Miller,
Christopher D Leach,
Christopher T Middendorf,
Christopher T Peters,
Clotia Cabbey Mensah,
Creighton T Tuzon,
Daniel C Kearns,
Daniel Kearns,
David J Gasparovich,
David Perkins,
Dawnna D Brown,
Debra I Love,
Debra Lboyd Seale,
Decarlos A Gomez,
Denarvis C Mendenhall,
Dennis Cantellops Paite,
Dolores Harper,
Dr. Carmelo Rosa,
Dr. Guang Gao, PhD,
Elliot P Cowam, PhD,
Eric M Mueller, PharmD,
Gene D Arcy,
Greg Brinsley,
Gregory R Brinsley,
Helen B Ricalde,
Howard Sklamberg,
Humera T Khan,
James L Dunnie, Jr,
James W Plucinski,
Jan B Welch,
Janae D Price,
Jason F Chancey,
Jeanne J Thai,
Jeanne M Morris,
Jennifer C Adams,
Jennifer C Johnson,
Jeremy W Rotton,
Jesse A Vazquez,
Joan A Loreng,
John M Seale,
Jose Acruz Gonzalez,
Joseph A Morkunas,
Joseph A Piechocki,
Joshua M Adams,
Julie D Bringger,
Karen Emasley Joseph,
Kathleen B Swat,
Kimberly Lewandowski Walker,
Kujtim Sadiku,
Lakisha M Williams,
Laureen M Geniusz,
Lauren N Howard,
Lauren N Smith,
Laurie A Haxel,
Laurimer Kuilan Torres,
LCDR Chad N Thompson,
Lee Terry Moore,
Lequita M Mayhew,
Lisa Hayka,
Lorelei S Jarrell,
Lydia I Rosas Marty,
Margaret Torres Vazquez,
Mark G Peterson,
Mark I Kaspar,
Martha T Olone,
Mary E Storch,
Matthew J Sienko,
Matthew R Buenconsejo,
Maureen C Melvin,
Michael D Robinson,
Michael E Campbell,
Michele L Glendenning,
Mishelle L Harriger,
Nancy J Lucas,
Natasha R Johnson,
Nibin Varghese, MS,
Nicholas F Lyons,
Nicholas J Presto,
Nicholas L Paulin,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole J Clausen,
Nicole K Trudel,
Nicole S Williams,
Norman K Starks,
Norman Wong,
Omotunde O Osunsanmi,
Pablo Alcantara,
Patricia A Mcilroy,
Peng Zhou,
Phung Thien Nguyen,
Prabhu P Raju,
Rafael Padilla,
Rebecca Rodriguez,
Robert J Ham,
Robert L Stevenson,
Roberta W Cunningham,
Roshni J Patel,
Russell K Riley,
Sandra A Hughes,
Sarah B Tanksley,
Sarah Nwandiuko,
Shafiq S Ahadi,
Shana L Williams,
Shannon A Gregory,
Stefen D Mcmillan,
Stephen C Mahoney,
Stephen D Eich,
Steven C Madzo,
Sullan,
Susan A Zullo, PhD,
Susan D Yuscius,
Susan M Jackson,
Susan P Bruederle,
Tamara Brey,
That Q Dang,
Todd M Stankewicz,
William R Weissinger,
Yiyue Zhang (nmi), PhD,
Yuanyuan Li,
Yvonne E Lozano
Lisa Hornback's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2000 | EIR | Fresenius Kabi USA, LLC - EIR, 2000-07-25 |
| April, 2000 | EIR | Abbott Laboratories - EIR, 2000-04-10 |
| April, 2000 | FDA 483 | Abbott Laboratories - Form 483, 2000-03-31 |
| September, 2000 | EIR | Davidson, Michael H., M.D. - EIR, 2000-09-15 |
| December, 2000 | EIR | Astellas Pharma US Inc. - EIR, 2001-01-17 |
| August, 2001 | EIR | Khurana, Chandra M. - EIR, 2001-08-29 |
| February, 2002 | FDA 483 | Angiotech (Manan Medical Products, Inc.) - Form 483, 2002-02-21 |
| August, 2001 | FDA 483 | Chandra Khurana - Form 483, 2001-08-29 |
| April, 2000 | FDA 483 Response | Abbott Laboratories - Form 483R, 2000-08-28 |
| April, 2000 | FDA 483 Response | Abbott Laboratories - Form 483R, 2000-04-13 |
| April, 2000 | EIR | Abbott Laboratories - EIR, 2000-03-31 |
| October, 2001 | EIR | Particle Technology Labs - EIR, 2001-10-05 |
| March, 2002 | FDA 483 | Theken Companies LLC - Form 483, 2002-03-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more